Medtronic Stock News

We believe Medtronic historically lost market share as the company does not operate in the high-growth IVD market.

Medtronic expects to return to pre-Covid growth in the current quarter, but MDT stock fell Tuesday on a fiscal third-quarter sales miss.

Medtronic Falls on Cutting Revenue Outlook After Q2 Miss

Medtronic's (MDT) Cardiac Cryoablation is the only ablation catheter approved to treat pediatric AVNRT.

Medtronic (MDT) delivered earnings and revenue surprises of 0.74% and 1.60%, respectively, for the quarter ended January 2022. Do the numbers hold clues to what lies ahead for the stock?

The surgical supply store reported third-quarter earnings on Tuesday, saying foreign exchange impacts could take a chunk off of top line earnings.

Medtronic (MDT) is trading flat in the pre-market on Tuesday after the company reported lower-than-expected revenue for Q3 fiscal 2022 and set its guidance for the current quarter in

Medtronic plc (MDT) CEO Geoff Martha on Q3 2022 Results - Earnings Call Transcript

Medtronic (MDT) registers organic growth in the Cardiovascular, Neuroscience and Diabetes segments in Q3.

Medtronic said Tuesday it expects procedure volumes in most of its markets to be back to pre-COVID level by the end of the fourth quarter. The medical device maker said its third-quarter net income rose 17% to $1.48 billion, or $1.10 a share, from $1.27 billion, or 94 cents a share, in the year-ago quarter. Adjusted earnings in the latest quarter were $1.37 per share, up 6%. Third-quarter revenue dipped 0.2% to $7.76 billion. The company fell a penny short of the Wall Street consensus estimate of $1.38 a share, and missing the revenue target of $7.95 billion, according to FactSet data. Looking ahead, Medtronic expects fourth-quarter adjusted earnings of $1.56 to $1.58 share, which includes a neutral to slightly positive impact from foreign currency, against a Wall Street estimate of $1.57 a share. CEO Geoff Martha said Medtronic expects healthcare procedures to reaccelerate post-Omicron. Shares of Medtronic rose 0.5% in premarket trades. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move.

Medtronic Plc reported a 16.5% rise in quarterly profit on Tuesday, as strong demand for its heart devices cushioned weakness in some other businesses during the Omicron-led surge in COVID-19 infections.

Medtronic (MDT) delivered earnings and revenue surprises of 0.74% and 1.60%, respectively, for the quarter ended January 2022. Do the numbers hold clues to what lies ahead for the stock?

Medtronic's (MDT) Cardiac Cryoablation is the only ablation catheter approved to treat pediatric AVNRT.

Medtronic MDT, -1.10% said Tuesday it expects procedure volumes in most of its markets to be back to pre-COVID level by the end of the fourth quarter. The medical device maker said its third-quarter n

Three digital health stocks are moving the needle for the fast-growing telehealth business. Let's have a look at TDOC, MDT and BFLY.